You are on Trendlyne United States. Click here to go to India website or make United States as your default
person reading

About ProMIS Neurosciences Inc. - Company Information, Overview, History and Profile

What does ProMIS Neurosciences Inc. do?

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

ProMIS Neurosciences Inc. Management structure

All Gross Remunerations are in USD
Mr. Gavin T. Malenfant
Chief Operating Officer
-
2025
Gross Remuneration
Year

ProMIS Neurosciences Inc. Board of directors

All Gross Remunerations are in USD
Mr. Neil K. Warma
Director, President and Chief Executive Officer
-
2024
Gross Remuneration
Year
Dr. Gail M. Farfel, PhD
President, Chief Executive Officer and Director
-
2024
Gross Remuneration
Year